# CITALOPRAM HYDROBROMIDE
> **ANDA077534** · Abbreviated New Drug Application (Generic) · Sponsor: INVAGEN PHARMS · Approved 2006-10-03
## Drug
- **FDA Application Number:** ANDA077534
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CITALOPRAM HYDROBROMIDE
- **Generic name:** CITALOPRAM
- **Active ingredients:** CITALOPRAM HYDROBROMIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** INVAGEN PHARMS
- **Manufacturer:** Cipla USA Inc.
- **First approval:** 2006-10-03
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077534)
---
*MORVS · CC0 1.0*